B Forseth - Concepedia

Author

B Forseth

The University of Texas Health Science Center at San Antonio

Also Known As

B Forseth, B J Forseth, B. J. Forseth, BARBARA FORSETH, Barbara Forseth, Barbara J. Forseth, Forseth, B

Publications

808

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Salk Institute for Biological Studies

About

B Forseth is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	755
2	Health Sciences	3	3	285
3	Natural Sciences	2	2	129
4	Engineering	1	1	50
5	Biochemistry	1	1	41

B Forseth

Publications

790

Citations

H-Index

Page 1

	Year	Citations
Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Daniel D. Von Hoff, J. McGill, B Forseth, Proceedings of the National Academy of Sciences GeneticsPathologyCancer BiologyEpigeneticsTumor Biology	1992	187
Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. S. Gail Eckhardt, Anna Dai, K K Davidson, Proceedings of the National Academy of Sciences C-myc ExpressionMolecular BiologyC-myc GenesCell CultureCell Proliferation	1994	108
Double minutes arise from circular extrachromosomal DNA intermediates which integrate into chromosomal sites in human HL-60 leukemia cells. Daniel D. Von Hoff, B Forseth, C.Nanette Clare, Journal of Clinical Investigation CytogeneticsMixed-phenotype Acute LeukemiaGeneticsChromosomal SitesMolecular Biology	1990	88
Activity of mitoxantrone in a human tumor cloning system. Von Hoff, Coltman Ca, B Forseth PubMed OncologyMedicineCancer Cell BiologyPathologyBiliary Tree Cancer	1981	88
Hydroxyurea accelerates loss of extrachromosomally amplified genes from tumor cells. Daniel D. Von Hoff, TA Waddelow, B Forseth, PubMed Gene AmplificationGeneticsTumor CellsCancer BiologyEpigenetics	1991	82
Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes. Daniel D. Von Hoff, B Forseth, M. Huong, PubMed Tissue EngineeringEngineeringBiofabricationBiomedical EngineeringPetri Dish Method	1986	50
Activity of 9–10 anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone]dihydrochloride (CL216,942) in a human tumor cloning system Daniel D. Von Hoff, Charles A. Coltman, B Forseth Cancer Chemotherapy and Pharmacology Tumor BiologyMedicinal ChemistryBiochemistryNatural Sciences4,5-Dihydro-1 H-imidazol-2-yl	1981	41
Simultaneous in vitro drug sensitivity testing on tumors from different sites in the same patient Daniel D. Von Hoff, Gary M. Clark, B Forseth, Cancer Drug Sensitivity ProfilesTumor BiologyDifferent SitesTherapeutic Drug MonitoringOncology	1986	39
Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system. Daniel D. Von Hoff, B Forseth, Larry E. Warfel PubMed Tumor BiologyTumoral PathologyChemoprevention StrategyAntineoplastic AgentsHuman Tumor	1985	32
Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents Axel-Rainer Hanauske, C. Kent Osborne, Gary C. Chamness, European Journal of Cancer and Clinical Oncology Egf-receptor BindingBreast OncologyOncologyAntineoplastic AgentsMedicine	1987	24

Page 1